Metraipolis › archive › dc_ee78dd75494c
Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41181480
- DOI
- 10.1097/ms9.0000000000003790
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:18:33.679Z
- SHA-256 of the archived text
5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7- Stable URL of this page
https://metraipolis.com/documento/dc_ee78dd75494c
How to cite
Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480 — Europe PMC (en), https://europepmc.org/article/MED/41181480 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee78dd75494c (Metraipolis archive dc_ee78dd75494c, sha256 5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7)
BibTeX
@misc{dcee78dd75494c,
title = {Precision oncology: AI's breakthrough in TNBC chemoresistance prediction — Europe PMC PMID:41181480},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41181480},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee78dd75494c; sha256 5aa940fff6d98a76603da9e529666af91bb0f5567108f7b073908e69287f78f7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181480. Agents can read the archived copy with the MCP tool read_document.